Skip to main content
OpenTrials

Clinical trial condition

Choroidal Neovascularization

Explore clinical trials studying Choroidal Neovascularization. Study availability and eligibility vary by location and protocol.

151 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Choroidal Neovascularization trial results

Completed

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

NCT05269966

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Asarwa, Ahmedabad, India
  • Novartis Investigative Site Ahmedabad, Gujarat, India
  • Novartis Investigative Site Bangalore, Karnataka, India
  • Novartis Investigative Site Chennai, Tamil Nadu, India
View Trial Details
Completed

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

NCT04264819

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 51 locations
View Trial Details
Completed

Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia

NCT00967850

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +7 more
Locations
  • INGO Santiago de Compostela, La Coruña, Spain
  • Hospital General Reina Sofía Espinardo, Murcia, Spain
  • Clínica Universitaria de Navarra Pamplona, Navarre, Spain
  • Instituto Oftalmológico de Alicante Alicante, Spain
View Trial Details
Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

NCT04597632

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Fort Lauderdale, Florida, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Minneapolis, Minnesota, United States
View all 60 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

NCT04005352

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Loma Linda, California, United States
  • Novartis Investigative Site Riverside, California, United States
View all 118 locations
View Trial Details
Completed

A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

NCT04239027

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +9 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 40 locations
View Trial Details

Related conditions